272 related articles for article (PubMed ID: 17147463)
1. Use and safety of anthroposophic medications in chronic disease: a 2-year prospective analysis.
Hamre HJ; Witt CM; Glockmann A; Tröger W; Willich SN; Kiene H
Drug Saf; 2006; 29(12):1173-89. PubMed ID: 17147463
[TBL] [Abstract][Full Text] [Related]
2. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
[TBL] [Abstract][Full Text] [Related]
3. Remedies containing Asteraceae extracts: a prospective observational study of prescribing patterns and adverse drug reactions in German primary care.
Jeschke E; Ostermann T; Lüke C; Tabali M; Kröz M; Bockelbrink A; Witt CM; Willich SN; Matthes H
Drug Saf; 2009; 32(8):691-706. PubMed ID: 19591533
[TBL] [Abstract][Full Text] [Related]
4. Use and safety of anthroposophic medications for acute respiratory and ear infections: a prospective cohort study.
Hamre HJ; Glockmann A; Fischer M; Riley DS; Baars E; Kiene H
Drug Target Insights; 2007; 2():209-19. PubMed ID: 21901075
[TBL] [Abstract][Full Text] [Related]
5. Anthroposophic medical therapy in chronic disease: a four-year prospective cohort study.
Hamre HJ; Witt CM; Glockmann A; Ziegler R; Willich SN; Kiene H
BMC Complement Altern Med; 2007 Apr; 7():10. PubMed ID: 17451595
[TBL] [Abstract][Full Text] [Related]
6. Anthroposophic therapies in chronic disease: the Anthroposophic Medicine Outcomes Study (AMOS).
Hamre HJ; Becker-Witt C; Glockmann A; Ziegler R; Willich SN; Kiene H
Eur J Med Res; 2004 Jul; 9(7):351-60. PubMed ID: 15337636
[TBL] [Abstract][Full Text] [Related]
7. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
8. Outcome of anthroposophic medication therapy in chronic disease: a 12-month prospective cohort study.
Hamre HJ; Witt CM; Glockmann A; Ziegler R; Kienle GS; Willich SN; Kiene H
Drug Des Devel Ther; 2009 Feb; 2():25-37. PubMed ID: 19920891
[TBL] [Abstract][Full Text] [Related]
9. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
[TBL] [Abstract][Full Text] [Related]
10. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
Jose J; Rao PG
Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
[TBL] [Abstract][Full Text] [Related]
13. Perceived adverse drug reactions among non-institutionalized children and adolescents in Germany.
Knopf H; Du Y
Br J Clin Pharmacol; 2010 Sep; 70(3):409-17. PubMed ID: 20716242
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
[TBL] [Abstract][Full Text] [Related]
15. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
Svendsen K; Wood M; Olsson E; Nordeng H
Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
[TBL] [Abstract][Full Text] [Related]
16. Anthroposophic vs. conventional therapy of acute respiratory and ear infections: a prospective outcomes study.
Hamre HJ; Fischer M; Heger M; Riley D; Haidvogl M; Baars E; Bristol E; Evans M; Schwarz R; Kiene H
Wien Klin Wochenschr; 2005 Apr; 117(7-8):256-68. PubMed ID: 15926617
[TBL] [Abstract][Full Text] [Related]
17. Adverse Drug Reactions in Children--International Surveillance and Evaluation (ADVISE): a multicentre cohort study.
Rashed AN; Wong IC; Cranswick N; Hefele B; Tomlin S; Jackman J; Lee K; Hon KL; Ong J; Ghaleb M; Chua SS; Hui TM; Rascher W; Neubert A
Drug Saf; 2012 Jun; 35(6):481-94. PubMed ID: 22612852
[TBL] [Abstract][Full Text] [Related]
18. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
Aagaard L; Weber CB; Hansen EH
Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.
van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH
Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543
[TBL] [Abstract][Full Text] [Related]
20. Frequency and preventability of adverse drug reactions in paediatric patients.
Temple ME; Robinson RF; Miller JC; Hayes JR; Nahata MC
Drug Saf; 2004; 27(11):819-29. PubMed ID: 15350153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
